Editorial
Accepted on 21 Mar 2025
Editorial: Allergies and Anti-allergy Drug Discovery in Africa
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1593023
Type at least 3 characters
623 articles
Articles
Original Research
Published on 21 Mar 2025
Association between vaccination, viral antibodies, and asthma prevalence in the U.S.: insights from NHANES (1999–2020)
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1456934
- 127 views
Study Protocol
Published on 21 Mar 2025
Study protocol for a randomized double-blinded placebo-controlled trial on mepolizumab for patients with chronic rhinosinusitis with nasal polyps, NSAID exacerbated respiratory disease and asthma
in Rhinology
Frontiers in Allergy
doi 10.3389/falgy.2025.1568081
- 176 views
Original Research
Published on 20 Mar 2025
Durability of benralizumab effectiveness in severe eosinophilic asthma patients with and without chronic rhinosinusitis with nasal polyps: a post hoc analysis from the ANANKE study
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1501196
- 248 views
Correction
Published on 20 Mar 2025
Corrigendum: Gut microbiome features in pediatric food allergy: a scoping review
in Food Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1588779
Original Research
Published on 20 Mar 2025
Respiratory symptoms, sensitisation and occupational exposure in the shrimp processing industry
in Environmental & Occupational Determinants
Frontiers in Allergy
doi 10.3389/falgy.2025.1520576
- 161 views
Review
Accepted on 19 Mar 2025
Biologic therapies and CRSwNP How does asthma coexistence affect the Strategic Selection of Biologic Therapies in CRSwNP Management?
in Rhinology
Frontiers in Allergy
doi 10.3389/falgy.2025.1579224
Original Research
Published on 19 Mar 2025
Food allergen introduction practices and parent/caregiver attitudes based on family history of food allergy
in Food Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1562667
- 153 views
Original Research
Accepted on 18 Mar 2025
Fire ant venom anaphylaxis prevalence in the general population and patients with systemic mastocytosis
in Drug, Venom & Anaphylaxis
Frontiers in Allergy
doi 10.3389/falgy.2025.1570123
Methods
Accepted on 17 Mar 2025
Multiplex IgE peanut panels: critical appraisal of assay designs and the overall good, the bad and the ugly features of the applied allergen components
in Allergy Diagnosis
Frontiers in Allergy
doi 10.3389/falgy.2025.1515294
Original Research
Accepted on 17 Mar 2025
Association Between the CALLY Index, Vitamin D, and Asthma
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1557677
Brief Research Report
Accepted on 17 Mar 2025
Development and Validation of a Delphi Consensus-Based Questionnaire for the Multidisciplinary Management of Type 2 Inflammation-Related Diseases
in Allergy Diagnosis
Frontiers in Allergy
doi 10.3389/falgy.2025.1543504
Community Case Study
Accepted on 17 Mar 2025
Exposure to outdoor aerospora and associated respiratory health risks among adults in Potchefstroom, North-West province, South Africa
in Mechanisms in Allergy
Frontiers in Allergy
doi 10.3389/falgy.2025.1568669
Clinical Trial
Accepted on 17 Mar 2025
A Randomized Controlled Trial Evaluating Prophylactic Treatment of Artemisia Pollinosis Using Azelastine Hydrochloride and Fluticasone Propionate Nasal Spray
in Therapies and Therapeutic Targets
Frontiers in Allergy
doi 10.3389/falgy.2025.1559201
Hypothesis and Theory
Accepted on 17 Mar 2025
The Acari Hypothesis, VII: Accounting for the Comorbidity of Allergy with Other Contemporary Medical Conditions, Especially Metabolic Syndrome
in Infections and Microbiome
Frontiers in Allergy
doi 10.3389/falgy.2025.1537467
Original Research
Published on 17 Mar 2025
Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
in Asthma
Frontiers in Allergy
doi 10.3389/falgy.2025.1537501
- 265 views